
The Wisdom Core of Breast Milk: 2'-FL, Building a Golden Line of Defense in the Early Stages of Life
Among the thousands of essences in breast milk, there is an ingredient known as the "golden immune factor" - 2'-Fucosyllactose (2'-fucosyllactose, abbreviated as 2'-FL). As the most abundant human milk oligosaccharide (HMOs), 2'-FL is the first health gift given by nature to newborns, and it is also the key code for modern nutritional science to unlock the health of early life.
The core efficacy of 2'-FL lies in its unique dual role as a prebiotic and immune regulator. It cannot be directly digested by the human body, but it can accurately become an exclusive "delicacy" for beneficial bacteria (such as bifidobacteria) in the baby's intestines, helping to establish a healthy intestinal microecology dominated by beneficial bacteria [1]. A balanced intestinal flora is the basis for strong digestion and absorption functions and a healthy immune system.
More importantly, 2'-FL plays the role of "immune bait". It can attract harmful pathogens (such as E. coli and Salmonella) like a magnet, thus preventing these pathogens from attaching to the delicate intestinal wall of the baby and eventually being excreted from the body, reducing the risk of infection from the source [2]. This passive immune protection mechanism is an important reason why breastfed babies have stronger resistance.
Today, through advanced biosynthesis technology, pure 2'-FL can be added to infant formula and other functional foods, so that non-breastfed babies can also get this precious protection from breast milk. Choosing 2'-FL means choosing to be close to nature and laying the most solid foundation for the healthy growth of your baby.
References :
1.Bode, L. (2012). "Human milk oligosaccharides: Every baby needs a sugar mama." Glycobiology, 22(9), 1147-1162.
2.Pacheco, A. R., et al. (2015). "Fucosyltransferase 2 status and personal microbiota: The example of 2'-fucosyllactose." Current Opinion in Clinical Nutrition & Metabolic Care, 18(4), 329-335.


